ReviewWorld journal of gastroenterology2016
Percutaneous ablation of pancreatic cancer.
Review in World journal of gastroenterology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Non-Invasive Pancreas Ablation Using Histotripsy: Pre-clinical Safety Study in an In Vivo Porcine Model.Ultrasound in medicine & biology · 2026Article
- Percutaneous radiofrequency ablation of pancreatic insulinoma: A case report and literature review.Radiology case reports · 2025Article
- Hypertension and tachycardia induced by irreversible electroporation in pancreatic cancer: An analysis based on clinical data.World journal of gastrointestinal surgery · 2025Article
- Technical Feasibility of Microwave Ablation in Pancreatic Tumors: A Scoping Review of Procedural Efficacy and Safety.Cancers · 2025Review
- Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Adenocarcinoma: A Scoping Review with Meta-Analysis.Diagnostics (Basel, Switzerland) · 2025Review
- Review
- Endoscopic Ultrasound-Guided Ablation of Premalignant Pancreatic Cysts and Pancreatic Cancer.Diagnostics (Basel, Switzerland) · 2024Review
- Article
- Percutaneous cryoablation of follicular thyroid carcinoma metastasis to the pancreasDiagnostic and interventional radiology (Ankara, Turkey) · 2023Article
- Ultrasound-guided noninvasive pancreas ablation using histotripsy: feasibility study in anInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group · 2023Article
- Nine-year survival of a 60-year-old woman with locally advanced pancreatic cancer under repeated open approach radiofrequency ablation: A case report.World journal of clinical cases · 2022Article
- EUS-RFA of the pancreas: where are we and future directions.Translational gastroenterology and hepatology · 2022Review
- Laparoscopic ultrasonography-guided cryoablation of locally advanced pancreatic cancer: a preliminary report.Japanese journal of radiology · 2022Article
- Clinical practice guidelines for the interventional treatment of advanced pancreatic cancer (5Journal of interventional medicine · 2021Article
- The role of interventional radiology in the treatment of patients with pancreatic cancer.The British journal of radiology · 2021Review
- A Multimodal Pancreas Phantom for Computer-Assisted Surgery Training.IEEE open journal of engineering in medicine and biology · 2020Article
- Treatment of Insulinomas by Laparoscopic Radiofrequency Ablation: Case Reports and Literature Review.Open medicine (Warsaw, Poland) · 2020Article
- High-resolution intravascular MRI-guided perivascular ultrasound ablation.Magnetic resonance in medicine · 2020Article
- Ultrasound-guided percutaneous procedures in pancreatic diseases: new techniques and applications.European radiology experimental · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pancreatic ductal adenocarcinoma is a highly aggressive tumor with an overall 5-year survival rate of less than 5%. Prognosis and treatment depend on whether the tumor is resectable or not, which mostly depends on how quickly the diagnosis is made. Chemotherapy and radiotherapy can be both used in cases of non-resectable pancreatic cancer. In cases of pancreatic neoplasm that is locally advanced, non-resectable, but non-metastatic, it is possible to apply percutaneous treatments that are able to induce tumor cytoreduction. The aim of this article will be to describe the multiple currently available treatment techniques (radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation), their results, and their possible complications, with the aid of a literature review.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.